The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Open accessAbstract
The discovery and implementation of antibiotics in the early twentieth century transformed human health and wellbeing. Chemical synthesis enabled the development of the first antibacterial substances, organoarsenicals and sulfa drugs, but these were soon outshone by a host of more powerful and vastly more complex antibiotics from nature: penicillin, streptomycin, tetracycline, and erythromycin, among others. These primary defences are now significantly less effective as an unavoidable consequence of rapid evolution of resistance within pathogenic bacteria, made worse by widespread misuse of antibiotics. For decades medicinal chemists replenished the arsenal of antibiotics by semisynthetic and to a lesser degree fully synthetic routes, but economic factors have led to a subsidence of this effort, which places society on the precipice of a disaster. We believe that the strategic application of modern chemical synthesis to antibacterial drug discovery must play a critical role if a crisis of global proportions is to be averted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
A New Method of Forming Peptide Bonds
Sheehan, J. C., & Hess, G. P. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01609a099 · Cited by 1,265
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
The bacterial ribosome as a target for antibiotics
Poehlsgaard, J., & Douthwaite, S. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1265 · Cited by 607
Penicillin as a Chemotherapeutic Agent
Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J., & Sanders, A. G. (1940) · The Lancet · doi:10.1016/s0140-6736(01)08728-1 · Cited by 603
Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces
Hendlin, D., Stapley, E. O., Jackson, M., Wallick, H., Miller, A. K., Wolf, F. J., Miller, T. W., Chaiet, L., Kahan, F. M., Foltz, E. L., et al. (1969) · Science · doi:10.1126/science.166.3901.122 · Cited by 593
Brickner, S. J., Hutchinson, D. K., Barbachyn, M. R., Manninen, P. R., Ulanowicz, D. A., Garmon, S. A., Grega, K. C., Hendges, S. K., Toops, D. S., Ford, C. W., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9509556 · Cited by 582
The Structures of Four Macrolide Antibiotics Bound to the Large Ribosomal Subunit
Hansen, J. L., Ippolito, J. A., Ban, N., Nissen, P., Moore, P. B., & Steitz, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00570-1 · Cited by 568
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections
Steenbergen, J. N., Alder, J., Thorne, G. M., & Tally, F. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh546 · Cited by 561
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200528 · Cited by 553
Clarke, H. (1949) · Princeton University Press eBooks · doi:10.1515/9781400874910 · Cited by 552
RifamycinMode of Action, Resistance, and Biosynthesis
Floss, H. G., & Yu, T.-W. (2005) · Chemical Reviews · doi:10.1021/cr030112j · Cited by 547
Lantibiotics: Mode of Action, Biosynthesis and Bioengineering
Bierbaum, G., & Sahl, H.-G. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048616 · Cited by 524
KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514
AUREOMYCIN: A PRODUCT OF THE CONTINUING SEARCH FOR NEW ANTIBIOTICS
Duggar, B. M. (1948) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1948.tb27262.x · Cited by 512
Koga, H., Itoh, A., Murayama, S., Suzue, S., & Irikura, T. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00186a014 · Cited by 486
The history of African trypanosomiasis
Steverding, D. (2008) · Parasites & Vectors · doi:10.1186/1756-3305-1-3 · Cited by 470
Brahams, D. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90167-8 · Cited by 440
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Tu, D., Blaha, G., Moore, P. B., & Steitz, T. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.005 · Cited by 433
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Sneader, W. (2005) · Wiley eBooks · doi:10.1002/0470015535 · Cited by 427
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Daum, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070747 · Cited by 417
Dunkle, J. A., Xiong, L., Mankin, A. S., & Cate, J. H. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007988107 · Cited by 413
Paul Ehrlich (1854-1915) and His Contributions to the Foundation and Birth of Translational Medicine
Valent, P., Groner, B., Schumacher, U., Superti-Furga, G., Busslinger, M., Kralovics, R., Zielinski, C., Penninger, J. M., Kerjaschki, D., Stingl, G., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000443526 · Cited by 409
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Chloromycetin, a New Antibiotic From a Soil Actinomycete
Ehrlich, J., Bartz, Q. R., Smith, R. M., Joslyn, D. A., & Burkholder, P. R. (1947) · Science · doi:10.1126/science.106.2757.417 · Cited by 399
Hansen, J. L., Moore, P. B., & Steitz, T. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00668-5 · Cited by 393
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Sulfazecin and isosulfazecin, novel β-lactam antibiotics of bacterial origin
Imada, A., Kitano, K., Kintaka, K., Muroi, M., & Asai, M. (1981) · Nature · doi:10.1038/289590a0 · Cited by 335
Pogliano, J., Pogliano, N., & Silverman, J. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.00011-12 · Cited by 319
History of the Development of Rifampin
Sensi, P. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s402 · Cited by 315
Lewis, J. S., & Jorgensen, J. H. (2005) · Clinical Infectious Diseases · doi:10.1086/426894 · Cited by 313
NDM-1 — A Cause for Worldwide Concern
Moellering, R. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011715 · Cited by 312
Revisiting the structures of several antibiotics bound to the bacterial ribosome
Bulkley, D., Innis, C. A., Blaha, G., & Steitz, T. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008685107 · Cited by 308
Monocyclic β-lactam antibiotics produced by bacteria
Sykes, R. B., Cimarusti, C. M., Bonner, D. P., Bush, K., Floyd, D. M., Georgopapadakou, N. H., Koster, W. H., Liu, W. C., Parker, W. L., Principe, P. A., et al. (1981) · Nature · doi:10.1038/291489a0 · Cited by 304
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
Ippolito, J. A., Kanyo, Z. F., Wang, D., Franceschi, F. J., Moore, P. B., Steitz, T. A., & Duffy, E. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800379d · Cited by 303
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005) · Science · doi:10.1126/science.1109755 · Cited by 298
Self-citationThe structure of cephalosporin C
Abraham, E. P., & Newton, G. G. F. (1961) · Biochemical Journal · doi:10.1042/bj0790377 · Cited by 296
RIEDLINGER, J., REICKE, A., ZÄHNER, H., KRISMER, B., BULL, A. T., MALDONADO, L. A., WARD, A. C., GOODFELLOW, M., BISTER, B., BISCHOFF, D., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.271 · Cited by 296
Bosch, F., & Rosich, L. (2008) · Pharmacology · doi:10.1159/000149583 · Cited by 292
Combinatorial biosynthesis of novel antibiotics related to daptomycin
Nguyen, K. T., Ritz, D., Gu, J.-Q., Alexander, D., Chu, M., Miao, V., Brian, P., & Baltz, R. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608589103 · Cited by 287
The development of drugs for treatment of sleeping sickness: a historical review
Steverding, D. (2010) · Parasites & Vectors · doi:10.1186/1756-3305-3-15 · Cited by 274
Rifampicin: A New Orally Active Rifamycin
Maggi, N., Pasqualucci, C. R., Ballotta, R., & Sensi, P. (1966) · Chemotherapy · doi:10.1159/000220462 · Cited by 270
Total Syntheses of Vancomycin and Eremomycin Aglycons
Evans, D. A., Wood, M. R., Trotter, B. W., Richardson, T. I., Barrow, J. C., & Katz, J. L. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981016)37:19<2700::aid-anie2700>3.0.co;2-p · Cited by 268
Finlay, A. C., Hobby, G. L., P'an, S. Y., Regna, P. P., Routien, J. B., Seeley, D. B., Shull, G. M., Sobin, B. A., Solomons, I. A., Vinson, J. W., et al. (1950) · Science · doi:10.1126/science.111.2874.85 · Cited by 257
Woodward, R. B., Logusch, E., Nambiar, K. P., Sakan, K., Ward, D. E., Au-Yeung, B. W., Balaram, P., Browne, L. J., Card, P. J., & Chen, C. H. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a049 · Cited by 257
The Composition of Ehrlich's Salvarsan: Resolution of a Century‐Old Debate
Lloyd, N. C., Morgan, H. W., Nicholson, B. K., & Ronimus, R. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461471 · Cited by 256
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
IS ALZHEIMER'S DISEASE DISTINCT FROM NORMAL AGEING?
HOFMAN, A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92339-2 · Cited by 240
Schlünzen, F., Pyetan, E., Fucini, P., Yonath, A., & Harms, J. M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04346.x · Cited by 240
MORIMOTO, S., TAKAHASHI, Y., WATANABE, Y., & OMURA, S. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.187 · Cited by 233
Discovering new antimicrobial agents
Moellering, R. C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.018 · Cited by 227
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Recent Advances in the Chemistry and Biology of Naturally Occurring Antibiotics
Nicolaou, K. C., Chen, J. S., Edmonds, D. J., & Estrada, A. A. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200801695 · Cited by 225
Antibiotics: Where did we go wrong?
Overbye, K. M., & Barrett, J. F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03285-4 · Cited by 223
Antibiotic Discovery and Development
(2012) · Springer eBooks · doi:10.1007/978-1-4614-1400-1 · Cited by 222
Hebeisen, P., Heinze-Krauss, I., Angehrn, P., Hohl, P., Page, M. G. P., & Then, R. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.825-836.2001 · Cited by 219
Greenberg, W. A., Priestley, E. S., Sears, P. S., Alper, P. B., Rosenbohm, C., Hendrix, M., Hung, S.-C., & Wong, C.-H. (1999) · Journal of the American Chemical Society · doi:10.1021/ja9910356 · Cited by 217
Matt, T., Ng, C. L., Lang, K., Sha, S.-H., Akbergenov, R., Shcherbakov, D., Meyer, M., Duscha, S., Xie, J., Dubbaka, S. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204073109 · Cited by 210
Asymmetric total synthesis of erythromycin. 3. Total synthesis of erythromycin
Woodward, R. B., Logusch, E., Nambiar, K. P., Sakan, K., Ward, D. E., Au-Yeung, B. W., Balaram, P., Browne, L. J., Card, P. J., & Chen, C. H. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a051 · Cited by 205
Total Synthesis of the Vancomycin Aglycon
Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Castle, S. L., Loiseleur, O., & Jin, Q. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992577q · Cited by 201
Oral Fluoroquinolones and the Risk of Retinal Detachment
Forooghian, F. (2012) · JAMA · doi:10.1001/jama.2012.383 · Cited by 200
Acid degradation of erythromycin A and erythromycin B
Kurath, P., Jones, P. H., Egan, R. S., & Perun, T. J. (1971) · Experientia · doi:10.1007/bf02137246 · Cited by 199
Davidovich, C., Bashan, A., Auerbach-Nevo, T., Yaggie, R. D., Gontarek, R. R., & Yonath, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700041104 · Cited by 196
The Future of Aminoglycosides: The End or Renaissance?
Houghton, J. L., Green, K. D., Chen, W., & Garneau‐Tsodikova, S. (2010) · ChemBioChem · doi:10.1002/cbic.200900779 · Cited by 189
Nicolaou, K. C., Mitchell, H. J., Jain, N. F., Winssinger, N., Hughes, R. O., & Bando, T. (1999) · Angewandte Chemie International Edition · Cited by 187
Rifamycins – Obstacles and opportunities
Aristoff, P. A., Garcia, G. A., Kirchhoff, P. D., & Hollis Showalter, H. D. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.02.001 · Cited by 184
Ketolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.
COOPER, R. D. G., SNYDER, N. J., ZWEIFEL, M. J., STASZAK, M. A., WILKIE, S. C., NICAS, T. I., MULLEN, D. L., BUTLER, T. F., RODRIGUEZ, M. J., HUFF, B. E., et al. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.575 · Cited by 181
Cefuroxime, a New Cephalosporin Antibiotic: Activity In Vitro
O'Callaghan, C. H., SYKES, R. B., Griffiths, A., & Thornton, J. E. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.3.511 · Cited by 176
Artsimovitch, I., Vassylyeva, M. N., Svetlov, D., Svetlov, V., Perederina, A., Igarashi, N., Matsugaki, N., Wakatsuki, S., Tahirov, T. H., & Vassylyev, D. G. (2005) · Cell · doi:10.1016/j.cell.2005.07.014 · Cited by 174
Struktur und Biogenese der Makrolide
Woodward, R. B. (1957) · Angewandte Chemie · doi:10.1002/ange.19570690109 · Cited by 174
Sum, P.-E., & Petersen, P. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173
Harms, J. M., Schlünzen, F., Fucini, P., Bartels, H., & Yonath, A. (2004) · BMC Biology · doi:10.1186/1741-7007-2-4 · Cited by 171
THE TOTAL SYNTHESIS OF PENICILLIN V
Sheehan, J. C., & Henery-Logan, K. R. (1957) · Journal of the American Chemical Society · doi:10.1021/ja01562a063 · Cited by 170
Asymmetric total synthesis of erythromycin. 2. Synthesis of an erythronolide A lactone system
Woodward, R. B., Au-Yeung, B. W., Balaram, P., Browne, L. J., Ward, D. E., Au-Yeung, B. W., Balaram, P., Browne, L. J., Card, P. J., & Chen, C. H. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a050 · Cited by 170
Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie · doi:10.1002/ange.200600350 · Cited by 169
2-Deoxystreptamine: Central Scaffold of Aminoglycoside Antibiotics
Busscher, G. F., Rutjes, F. P. J. T., & van Delft, F. L. (2005) · Chemical Reviews · doi:10.1021/cr0404085 · Cited by 169
Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 164
Bauer, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh125 · Cited by 163
PYRIMIDINE DERIVATIVES AS ANTAGONISTS OF PTEROYLGLUTAMIC ACID
Hitchings, G. H., Elion, G. B., VanderWerff, H., & Falco, E. A. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57361-0 · Cited by 162
Are pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 160
The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine
Haller, J. S. (2007) · Journal of the History of Medicine and Allied Sciences · doi:10.1093/jhmas/jrm035 · Cited by 160
Clay, K. D., Hanson, J. S., Pope, S. D., Rissmiller, R. W., Purdum, P. P., & Banks, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200503210-00121 · Cited by 160
The Structure of Terramycin1,2
Hochstein, F. A., Stephens, C. R., Conover, L. H., Regna, P. P., Pasternack, R. F., Gordon, P. N., Pilgrim, F. J., Brunings, K. J., & Woodward, R. B. (1953) · Journal of the American Chemical Society · doi:10.1021/ja01118a001 · Cited by 160
Bergeron, J., Ammirati, M., Danley, D., James, L., Norcia, M., Retsema, J., Strick, C. A., Su, W. G., Sutcliffe, J., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2226 · Cited by 157
Total Synthesis of Daptomycin by Cyclization via a Chemoselective Serine Ligation
Lam, H. Y., Zhang, Y., Liu, H., Xu, J., Wong, C. T. T., Xu, C., & Li, X. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4012468 · Cited by 157
The structure of ribosomal protein S5 reveals sites of interaction with 16S rRNA
Ramakrishnan, V., & White, S. W. (1992) · Nature · doi:10.1038/358768a0 · Cited by 154
Mannopeptimycins, Novel Antibacterial Glycopeptides from Streptomyces hygroscopicus, LL-AC98
He, H., Williamson, R. T., Shen, B., Graziani, E. I., Yang, H., Sakya, S. M., Petersen, P. J., & Carter, G. T. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020257s · Cited by 150
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
Candiani, G., Abbondi, M., Borgonovi, M., Romanò, G., & Parenti, F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.179 · Cited by 150
Synthesis and Derivatization of Daptomycin: A Chemoenzymatic Route to Acidic Lipopeptide Antibiotics
Grünewald, J., Sieber, S. A., Mahlert, C., Linne, U., & Marahiel, M. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja045455t · Cited by 145
Crowley, B. M., & Boger, D. L. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0572912 · Cited by 145
Nicolaou, K. C., Natarajan, S., Li, H., Jain, N. F., Hughes, R. O., Solomon, M. E., Ramanjulu, J. M., Boddy, C. N. C., & Takayanagi, M. (1998) · Angewandte Chemie International Edition · Cited by 145
Xie, J. H., Pierce, J. G., James, R. C., Okano, A., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207142h · Cited by 140
Chemistry and Biology of Ramoplanin: A Lipoglycodepsipeptide with Potent Antibiotic Activity
Walker, S., Chen, L., Hu, Y., Rew, Y., Shin, D., & Boger, D. L. (2005) · Chemical Reviews · doi:10.1021/cr030106n · Cited by 139
Xie, J. H., Okano, A., Pierce, J. G., James, R. C., Stamm, S., Crane, C. M., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209937s · Cited by 138
A Robust Platform for the Synthesis of New Tetracycline Antibiotics
Sun, C., Wang, Q., Brubaker, J. D., Wright, P. M., Lerner, C., Noson, K., Charest, M. G., Siegel, D. R., Wang, Y.-M., & Myers, A. G. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806629e · Cited by 134
Self-citationExploiting current understanding of antibiotic action for discovery of new drugs
Chopra, I., Hesse, L., & O’Neill, A. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.13.x · Cited by 130
Structures of RNA polymerase–antibiotic complexes
Ho, M. X., Hudson, B. P., Das, K., Arnold, E., & Ebright, R. H. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.10.010 · Cited by 127
STUDIES ON ANALOGS OF PURINES AND PYRIMIDINES
Hitchings, G. H., Elion, G. B., Falco, E. A., et al. (1950) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1950.tb54032.x · Cited by 124
Dalbavancin: a novel antimicrobial
Chen, A. Y., Zervos, M., & Vazquez, J. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01318.x · Cited by 123
Total Synthesis of Abyssomicin C and atrop‐Abyssomicin C
Nicolaou, K. C., & Harrison, S. T. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601116 · Cited by 121
Total Synthesis of Vancomycin Aglycon—Part 3: Final Stages
Nicolaou, K. C., Takayanagi, M., Jain, N. F., Natarajan, S., Koumbis, A. E., Bando, T., & Ramanjulu, J. M. (1998) · Angewandte Chemie International Edition · Cited by 120
Singh, M., Petersen, P. J., Weiss, W. J., Janso, J. E., Luckman, S. W., Lenoy, E., Bradford, P. A., TESTA, R. T., & Greenstein, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.62-69.2003 · Cited by 119
Sum, P., LEE, V. J., TESTA, R. T., Hlavka, J. J., Ellestad, G. A., Bloom, J. D., Gluzman, Y., & Tally, F. P. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a023 · Cited by 118
Redesign of Glycopeptide Antibiotics: Back to the Future
James, R. C., Pierce, J. G., Okano, A., Xie, J. H., & Boger, D. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300007j · Cited by 118
Nicolaou, K. C., & Harrison, S. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja067083p · Cited by 117
Nicolaou, K. C., Jain, N. F., Natarajan, S., Hughes, R. O., Solomon, M. E., Li, H., Ramanjulu, J. M., Takayanagi, M., Koumbis, A. E., & Bando, T. (1998) · Angewandte Chemie International Edition · Cited by 117
Rifomycin, a new antibiotic; preliminary report.
Sensi, P., Margalith, P., & Mt, T. (1959) · PubMed · Cited by 116
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Postgenomic Strategies in Antibacterial Drug Discovery
Brötz‐Oesterhelt, H., & Saß, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.119 · Cited by 105
Paul Ehrlich: founder of chemotherapy
Kaufmann, S. H. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2582 · Cited by 104
Nicolaou, K. C., Mitchell, H. J., Jain, N. F., Bando, T., Hughes, R. O., Winssinger, N., Natarajan, S., & Koumbis, A. E. (1999) · Chemistry - A European Journal · Cited by 103
Erythromycin series. Part 11. Ring expansion of erythromycin A oxime by the Beckmann rearrangement
Djokić, S., Kobrehel, G., Lazarevski, G., Lopotar, N., Tamburašev, Z., Kamenar, B., Nagl, A., & Vickovic, I. (1986) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19860001881 · Cited by 103
Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs
Haruki, H., Pedersen, M. G., Gorska, K. I., Pojer, F., & Johnsson, K. (2013) · Science · doi:10.1126/science.1232972 · Cited by 101
Baker, W. R., Clark, J. D., Stephens, R. L., & Kim, K. H. (1988) · The Journal of Organic Chemistry · doi:10.1021/jo00245a038 · Cited by 96
The 6-Deoxytetracyclines. VII. Alkylated Aminotetracyclines Possessing Unique Antibacterial Activity
Martell, M. J., & Boothe, J. H. (1967) · Journal of Medicinal Chemistry · doi:10.1021/jm00313a009 · Cited by 90
Prokocimer, P., Bien, P. A., DeAnda, C., Pillar, C. M., & Bartizal, K. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00458-12 · Cited by 89
GUTHIKONDA, R. N., CAMA, L. D., & CHRISTENSEN, B. G. (1974) · Journal of the American Chemical Society · doi:10.1021/ja00831a050 · Cited by 85
The Total Synthesis of Moenomycin A
Taylor, J. G., Li, X., Oberthür, M., Zhu, W., & Kahne, D. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja065907x · Cited by 85
Page, M. G. P. (2012) · Antibiotic Discovery and Development · doi:10.1007/978-1-4614-1400-1_3 · Cited by 84
Total Synthesis of (+)‐Pleuromutilin
Fazakerley, N. J., Helm, M., & Procter, D. J. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300968 · Cited by 81
A Practical, Enantioselective Synthetic Route to a Key Precursor to the Tetracycline Antibiotics
Brubaker, J. D., & Myers, A. G. (2007) · Organic Letters · doi:10.1021/ol071377d · Cited by 80
Self-citationUnemo, M., Golparian, D., Skogen, V., Olsen, A. O., Moi, H., Syversen, G., & Hjelmevoll, S. O. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01775-12 · Cited by 80
Maeda, K., Osato, T., & UMEZAWA, H. (1953) · PubMed · Cited by 78
6-Deoxytetracyclines. IV. 1,2 Preparation, C-6 Stereochemistry, and Reactions
Stephens, C. R., Beereboom, J. J., Rennhard, H. H., Gordon, P. N., Murai, K., Blackwood, R. K., & von Wittenau, M. S. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00900a027 · Cited by 77
Bertrand, D., Bertrand, S., Neveu, E., & FERNANDES, P. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00840-10 · Cited by 76
Struktur‐Wirkungs‐Beziehungen von Oxazolidinonen: Grundlage der Entwicklung von Linezolid
Barbachyn, M. R., & Ford, C. W. (2003) · Angewandte Chemie · doi:10.1002/ange.200200528 · Cited by 76
Total synthesis of .beta.-lactam antibiotics. VII. Total synthesis of (+-)-1-oxacephalothin
CAMA, L. D., & CHRISTENSEN, B. G. (1974) · Journal of the American Chemical Society · doi:10.1021/ja00831a049 · Cited by 74
Synthesis and antibacterial activity of 6315-S, a new member of the oxacephem antibiotic.
Tsuji, T., SATOH, H., Narisada, M., Hamashima, Y., & Yoshida, T. (1985) · The Journal of Antibiotics · doi:10.7164/antibiotics.38.466 · Cited by 73
The total synthesis of dl-6-demethyl-6-deoxytetracycline
Korst, J. J., Johnston, J. D., Butler, K., Bianco, E. J., Conover, L. H., & Woodward, R. B. (1968) · Journal of the American Chemical Society · doi:10.1021/ja01004a041 · Cited by 72
Macrolide Resistance in Staphylococcus aureus : Inducers of Macrolide Resistance
Allen, N. E. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.4.669 · Cited by 69
The Enchanted Ring. The untold story of penicillin
Johnson, A. W. (1983) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(83)90055-5 · Cited by 67
BARRIERE, J. ‐., Bouanchaud, D. H., Paris, J. M., et al. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.suppl_a.1 · Cited by 67
3-Benzyloxyisoxazole system in construction of tetracyclines
Stork, G., & Hagedorn, A. A. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00479a060 · Cited by 65
Synthesis and Antibacterial Activity of Pentacyclines: A Novel Class of Tetracycline Analogs
Sun, C., Hunt, D. K., Clark, R. B., Lofland, D., O’Brien, W. J., Plamondon, L., & Xiao, X.-Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1015395 · Cited by 64
Die Bekämpfung multiresistenter Bakterien: aktuelle Strategien zur Entdeckung neuer Antibiotika
O’Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie · doi:10.1002/ange.201209979 · Cited by 63
The Synthesis of Active and Stable Diaminopimelate Analogues of the Lantibiotic Peptide Lactocin S
Ross, A. C., McKinnie, S. M. K., & Vederas, J. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211088m · Cited by 63
Tetracyclines. 9. Total synthesis of dl-terramycin
Muxfeldt, H., Haas, G. W., Hardtmann, G. E., Kathawala, F., Mooberry, J. B., & Vedējs, E. (1979) · Journal of the American Chemical Society · doi:10.1021/ja00497a035 · Cited by 63
Further observations on penicillin. 1941.
Abraham, E. P., Chain, E. B., Cm, F., Florey, H. W., Ad, G., HEATLEY, N. G., & Ma, J. (1992) · PubMed · Cited by 62
Estebanez, A., Pascual, R., Gil, V., Ortiz, F., Santibáñez, M., & Barba, C. P. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0805-6 · Cited by 62
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
Ronn, M., Zhu, Z., Hogan, P. C., Zhang, W., Niu, J., Katz, C. E., Dunwoody, N., Gilicky, O., Deng, Y., Hunt, D. K., et al. (2013) · Organic Process Research & Development · doi:10.1021/op4000219 · Cited by 62
Church, R. F. R., Schaub, R. E., & Weiss, M. J. (1971) · The Journal of Organic Chemistry · doi:10.1021/jo00804a025 · Cited by 58
HYDROGENOLYSIS STUDIES IN THE TETRACYCLINE SERIES—6-DEOXYTETRACYCLINES
Stephens, C. R., Murai, K., Rennhard, H. H., Conover, L. H., & Brunings, K. J. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01552a082 · Cited by 57
Knerr, P. J., & van der Donk, W. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4014024 · Cited by 56
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin
Hill, J., Siedlecki, J. M., Parr, I. B., Morytko, M. J., Yu, X., Zhang, Y., Silverman, J. A., Controneo, N., Laganas, V. A., Li, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.019 · Cited by 55
Tetracyclines. VII. Total synthesis of dl-terramycin
Muxfeldt, H., Hardtmann, G. E., Kathawala, F., Vedējs, E., & Mooberry, J. B. (1968) · Journal of the American Chemical Society · doi:10.1021/ja01025a063 · Cited by 54
A practical, convergent route to the key precursor to the tetracycline antibiotics
Kummer, D. A., Li, D., Dion, A., & Myers, A. G. (2011) · Chemical Science · doi:10.1039/c1sc00303h · Cited by 53
Self-citationCorey, G. R., Stryjewski, M. E., Weyenberg, W., Yasothan, U., & Kirkpatrick, P. N. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3051 · Cited by 53
Garau, J., Wilson, W. R., Wood, M., & Carlet, J. M. (1997) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1997.tb00649.x · Cited by 52
Fortschritte in der Chemie und Biologie natürlicher Antibiotika
Nicolaou, K. C., Chen, J. S., Edmonds, D. J., & Estrada, A. A. (2009) · Angewandte Chemie · doi:10.1002/ange.200801695 · Cited by 52
Tuning the Moenomycin Pharmacophore To Enable Discovery of Bacterial Cell Wall Synthesis Inhibitors
Gampe, C. M., Tsukamoto, H., Doud, E. H., Walker, S., & Kahne, D. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4000933 · Cited by 51
Total Synthesis of Azithromycin
Kim, H. C., & Kang, S. H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805334 · Cited by 48
Drews, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1498 · Cited by 44
A Convergent, Enantioselective Total Synthesis of Streptogramin Antibiotic (−)-Madumycin II
Ghosh, A. K., & Liu, W. (1997) · The Journal of Organic Chemistry · doi:10.1021/jo971616i · Cited by 44
8-Azatetracyclines: Synthesis and Evaluation of a Novel Class of Tetracycline Antibacterial Agents
Clark, R. B., He, M., Fyfe, C., Lofland, D., O’Brien, W. J., Plamondon, L., Sutcliffe, J. A., & Xiao, X.-Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1015389 · Cited by 42
Total synthesis of erythromycin B
Breton, P., Hergenrother, P. J., HIDA, T., Hodgson, A., Judd, A. S., Kraynack, E., Kym, P. R., Lee, W., Loft, M. S., Yamashita, M., et al. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.02.044 · Cited by 42
McCormick, J. R. D., Jensen, E. R., Miller, P., & Doerschuk, A. P. (1960) · Journal of the American Chemical Society · doi:10.1021/ja01498a037 · Cited by 42
Total Synthesis of (−)‐Virginiamycin M2
Wu, J., & Panek, J. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002220 · Cited by 40
Mendes, R. E., Woosley, L. N., Farrell, D. J., Sader, H. S., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06067-11 · Cited by 37
Gurevich, A. I., Karapetyan, M. G., Kolosov, M. N., Korobko, V. G., Onoprienko, V. V., Popravko, S. A., & Shemyakin, M. M. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)90501-x · Cited by 33
Synthesis and biological evaluation of optically active 3-H-1-carbacephem compounds.
Ogasa, T., Saito, H., Hashimoto, Y., Sato, K., & Hirata, T. (1989) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.37.315 · Cited by 33
Wright, P. M., & Myers, A. G. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.09.143 · Cited by 33
Self-citationExpanding the pleuromutilin class of antibiotics by de novo chemical synthesis
Lotesta, S. D., Liu, J., Yates, E. V., Krieger, I. V., Sacchettini, J. C., Freundlich, J. S., & Sorensen, E. J. (2011) · Chemical Science · doi:10.1039/c1sc00116g · Cited by 29
Desmethyl Macrolides: Synthesis and Evaluation of 4-Desmethyl Telithromycin
Glassford, I., Lee, M., Wagh, B., Velvadapu, V., Paul, T., Sandelin, G., DEBROSSE, C. W., Klepacki, D., Small, M. C., MacKerell, A. D., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5002097 · Cited by 28
Desmethyl Macrolides: Synthesis and Evaluation of 4,8,10-Tridesmethyl Telithromycin
Velvadapu, V., Paul, T., Wagh, B., Klepacki, D., Guvench, O., MacKerell, A. D., & Andrade, R. B. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1002184 · Cited by 28
Desmethyl Macrolides: Synthesis and Evaluation of 4,10-Didesmethyl Telithromycin
Velvadapu, V., Glassford, I., Lee, M., Paul, T., DEBROSSE, C. W., Klepacki, D., Small, M. C., MacKerell, A. D., & Andrade, R. B. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200254h · Cited by 25
De Novo Formal Synthesis of (−)-Virginiamycin M2 via the Asymmetric Hydration of Dienoates
Mortensen, M. S., Osbourn, J. M., & O'Doherty, G. A. (2007) · Organic Letters · doi:10.1021/ol071145e · Cited by 23
He, Y. Q., Li, J., Yin, N., Herradura, P. S., Martel, L., Zhang, Y., Pearson, A. L., Kulkarni, V., Mascio, C. T. M., Howland, K., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.013 · Cited by 23
Mitton‐Fry, M. J., Arcari, J. T., Brown, M. F., Casavant, J. M., Finegan, S. M., Flanagan, M. E., Gao, H., George, D. M., Gerstenberger, B. S., Han, S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.005 · Cited by 20
Desmethyl Macrolides: Synthesis and Evaluation of 4,8-Didesmethyl Telithromycin
Wagh, B., Paul, T., Glassford, I., DEBROSSE, C. W., Klepacki, D., Small, M. C., MacKerell, A. D., & Andrade, R. B. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300230h · Cited by 18
Synthesis of 6-thiatetracycline, a highly active analogue of the antibiotic tetracycline
Kirchlechner, R., & Rogalski, W. (1980) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)71180-4 · Cited by 16
Total Synthesis of (−)‐Virginiamycin M2
Wu, J., & Panek, J. S. (2010) · Angewandte Chemie · doi:10.1002/ange.201002220 · Cited by 11
An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin
Yoganathan, S., Yin, N., He, Y. Q., Mesleh, M. F., Gu, Y. G., & Miller, S. J. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob40924d · Cited by 10
Total Synthesis of Azithromycin
Kim, H. C., & Kang, S. H. (2009) · Angewandte Chemie · doi:10.1002/ange.200805334 · Cited by 9
Cited by
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Antibacterial Activity of Silver Nanoparticles: Structural Effects
Tang, S., & Zheng, J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701503 · Cited by 1,205
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Expanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Metadata
- Authors
- Wright, P. M., Seiple, I. B., & Myers, A. G.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-07-02
- Volume
- 53
- Issue
- 34
- Pages
- 8840-8869
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2138298207
- Cited by
- 426
- References
- 193
- FWCI
- 23.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.